Private Equity Buyouts Are on Their Way Back, Deutsche Bank Says
(Bloomberg) -- Private equity firms are waiting to put about $1.5 trillion of unspent money to use. And their bankers are getting impatient.
With buyouts down 28% globally this year, according to Bloomberg data, there's growing optimism among some dealmakers that private equity titans will soon start splashing some cash again. Mark Fedorcik, who leads investment banking at Deutsche Bank AG, said he sees multi-billion dollar leveraged buyouts returning in the second half as credit markets reopen.
“There's a very limited pipeline of committed transactions as you get to the fall, so the market will be potentially looking for deals,” Fedorcik said in a phone interview this week. “That will lend itself to banks and other investors to want to do deals.”
Banks are hoping that private equity will help prop up an otherwise meager year for transactions, with many large corporations either constrained or cautious. As Covid-19 continues to wreak havoc on global economies, large buyout funds are biding their time and picking their spots -- such as health care and technology -- for a post-pandemic world.
And while credit markets have come roaring back with central bank support globally, leveraged loans in particular have been more sluggish.
Philip Drury, who leads Citigroup's banking, capital markets and advisory business in Europe, the Middle East and Africa, said investors will be cautious in factoring in risk and choosing sectors.
“We'll see a pick up in activity, no doubt, in the second half,” Drury said Friday on a Bloomberg Television interview. “Whether it's the third quarter, let's see.”
©2020 Bloomberg L.P.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.